Freitag, H., Christen, F., Lewens, F., Grass, I., Briest, F., Iwaszkiewicz, S., . . . Grabowski, P. (2017). Inhibition of mTOR's Catalytic Site by PKI-587 Is a Promising Therapeutic Option for Gastroenteropancreatic Neuroendocrine Tumor Disease. Neuroendocrinology.

Freitag, Helma, Friederike Christen, Florentine Lewens, Irina Grass, Franziska Briest, Sara Iwaszkiewicz, Britta Siegmund, i Patricia Grabowski. "Inhibition of MTOR's Catalytic Site By PKI-587 Is a Promising Therapeutic Option for Gastroenteropancreatic Neuroendocrine Tumor Disease." Neuroendocrinology 2017.

Freitag, Helma, et al. "Inhibition of MTOR's Catalytic Site By PKI-587 Is a Promising Therapeutic Option for Gastroenteropancreatic Neuroendocrine Tumor Disease." Neuroendocrinology 2017.